Organogenesis (ORGO) News Today → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free ORGO Stock Alerts $2.31 -0.13 (-5.33%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating on ORGO: Promising ReNu Trial Results and Significant Market Opportunitymarkets.businessinsider.com - May 3 at 9:47 PMOrganogenesis Holdings Inc. Class A Common Stock (ORGO)nasdaq.com - May 3 at 3:42 AMOrganogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritisglobenewswire.com - May 2 at 7:00 AMOrganogenesis (ORGO) to Release Quarterly Earnings on Thursdayamericanbankingnews.com - May 2 at 2:20 AMOrganogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024globenewswire.com - April 16 at 7:30 AMOrganogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Caseglobenewswire.com - April 3 at 7:30 AMBuy Rating Affirmed for Organogenesis Holdings Amid Stable Product Pricing and Positive Market Dynamicsmarkets.businessinsider.com - March 19 at 2:48 PMOrganogenesis Holdings Inc. Cl Abarrons.com - March 7 at 10:17 AMFY2024 EPS Estimates for Organogenesis Holdings Inc. (NASDAQ:ORGO) Decreased by Analystmarketbeat.com - March 6 at 8:12 AMOrganogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 2 at 12:42 PMOrganogenesis Holdings Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - March 2 at 12:42 PMWhy Organogenesis Holding Stock Plummeted by 18% Todayfool.com - March 1 at 6:29 PMOrganogenesis' (ORGO) Overweight Rating Reiterated at Cantor Fitzgeraldmarketbeat.com - March 1 at 9:37 AMmarketbeat.com - March 1 at 9:37 AMOrganogenesis (ORGO) Q4 2023 Earnings Call Transcriptmsn.com - March 1 at 1:48 AMRecap: Organogenesis Hldgs Q4 Earningsbenzinga.com - February 29 at 8:47 PMOrganogenesis Holdings Inc (ORGO) Faces Revenue Decline in Q4 and FY 2023, Aims for Growth in 2024finance.yahoo.com - February 29 at 8:47 PMOrganogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidanceglobenewswire.com - February 29 at 4:05 PMA Preview Of Organogenesis Hldgs's Earningsbenzinga.com - February 28 at 6:36 PMOrganogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Acadian Asset Management LLCmarketbeat.com - February 23 at 7:35 AMOrganogenesis Holdings Inc - Ordinary Shares - Class Amoney.usnews.com - February 15 at 10:45 AMOrganogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conferencefinance.yahoo.com - February 12 at 9:30 AMResearch Analysts Issue Forecasts for Organogenesis Holdings Inc.'s FY2023 Earnings (NASDAQ:ORGO)marketbeat.com - February 9 at 6:27 AMCantor starts Organogenesis at overweight, cites differentiated portfoliomsn.com - February 8 at 8:26 PMOrganogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024finance.yahoo.com - February 8 at 8:26 PMCantor Fitzgerald Initiates Coverage on Organogenesis (NASDAQ:ORGO)marketbeat.com - February 7 at 7:38 AMThompson Siegel & Walmsley LLC Purchases 338,448 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)marketbeat.com - February 4 at 7:41 AMAssenagon Asset Management S.A. Sells 393,523 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)marketbeat.com - February 2 at 5:48 AMLos Angeles Capital Management LLC Sells 145,952 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)marketbeat.com - January 31 at 5:54 AMAre You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choicefinance.yahoo.com - January 15 at 2:21 PMShareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested five years agofinance.yahoo.com - January 14 at 10:22 AMInsider Selling: Organogenesis Holdings Inc. (NASDAQ:ORGO) Major Shareholder Sells 197,921 Shares of Stockmarketbeat.com - January 11 at 6:38 PMOrganogenesis Hldgs Stock (NASDAQ:ORGO), Guidance and Forecastbenzinga.com - December 30 at 12:09 AMOrganogenesis (ORGO) is a Great Momentum Stock: Should You Buy?finance.yahoo.com - December 28 at 2:23 PMOrganogenesis (NASDAQ:ORGO) Shares Gap Up Following Analyst Upgrademarketbeat.com - December 27 at 10:18 AMOrganogenesis (NASDAQ:ORGO) PT Raised to $6.00marketbeat.com - December 27 at 8:12 AMOrganogenesis Holdings Inc. (NASDAQ:ORGO) Surges 42% Yet Its Low P/S Is No Reason For Excitementfinance.yahoo.com - December 18 at 9:59 AMOrganogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Is Going Strong: Have Financials A Role To Play?finance.yahoo.com - December 7 at 12:23 PMHere Is Why Bargain Hunters Would Love Fast-paced Mover Organogenesis (ORGO)msn.com - November 30 at 3:09 PMOrganogenesis Holdings Inc - (ORGO) Price Target Increased by 7.14% to 3.83msn.com - November 27 at 1:20 PM3 Biotech Stocks Flowing With Investment Potentialstocknews.com - November 24 at 7:08 PMOrganogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 11 at 1:46 PMDOCS, ORGO and GBIO are among pre market gainersmsn.com - November 10 at 12:09 PMThe recent US$46m market cap decrease is likely to have disappointed insiders invested in Organogenesis Holdings Inc. (NASDAQ:ORGO)finance.yahoo.com - November 10 at 12:09 PMOrganogenesis Holdings Inc. 2023 Q3 - Results - Earnings Call Presentationseekingalpha.com - November 9 at 10:19 PMOrganogenesis Holdings Inc. Reports Third Quarter 2023 Financial Resultsmarkets.businessinsider.com - November 9 at 9:07 PMOrganogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023finance.yahoo.com - October 5 at 11:23 AMWhy Shares of Organogenesis Holdings Are Up Thursdaymsn.com - September 29 at 1:59 PMOrganogenesis jumps after Medicare policy updateseekingalpha.com - September 28 at 7:07 PMOrganogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGSfinance.yahoo.com - September 28 at 2:06 PM Get Organogenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. ORGO Media Mentions By Week ORGO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORGO News Sentiment▼0.270.36▲Average Medical News Sentiment ORGO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORGO Articles This Week▼31▲ORGO Articles Average Week Get Organogenesis News Delivered to You Automatically Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kamada News CorMedix News Verrica Pharmaceuticals News Ventyx Biosciences News Neoleukin Therapeutics News Vanda Pharmaceuticals News UroGen Pharma News Atea Pharmaceuticals News Procaps Group News Nkarta News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORGO) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organogenesis Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
